I agree that this site is using cookies. You can find further informations here.
X
Yang, Tsai‐Sheng
71  results:
Search for persons X
?
1

Zinc supplementation is associated with improvement in hand..:

Lu, Chun-Wei ; Yeh, Chun-Nan ; Hsu, Hung-Chih...
Journal of the American Academy of Dermatology.  90 (2024)  4 - p. 814-815 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Zinc supplementation decreased incidence of grade ≥2 hand-f..:

Huang, Wen-Kuan ; Hsu, Hung-Chih ; Yang, Tsai-Sheng...
Journal of the American Academy of Dermatology.  90 (2024)  2 - p. 368-369 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Clinical characteristics and genetic HLA marker for patient..:

Hsu, Hung-Chih ; Chung, Wen-Hung ; Lin, Yung-Chang...
Allergology International.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Prospective, open‐label, and observational study of cetuxim..:

Yang, Tsai‐Sheng ; Chen, Hong‐Hwa ; Bo‐Wen, Lin...
Asia-Pacific Journal of Clinical Oncology.  19 (2023)  6 - p. 672-680 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Camrelizumab plus rivoceranib versus sorafenib as first-lin..:

Qin, Shukui ; Chan, Stephen L ; Gu, Shanzhi...
The Lancet.  402 (2023)  10408 - p. 1133-1146 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Zinc supplementation decreased incidence of grade ≥2 hand-f..:

Huang, Wen-Kuan ; Hsu, Hung-Chih ; Yang, Tsai-Sheng...
European Journal of Cancer.  195 (2023)  - p. 113286 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Risk of cardiovascular disease among different fluoropyrimi..:

Huang, Wen-Kuan ; Ho, Wei-Pang ; Hsu, Hung-Chih...
Frontiers in Cardiovascular Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Bevacizumab and atezolizumab as first-line therapy for adva..:

Shao, Yu-Yun ; Feng, Yin-Hsun ; Yen, Chia-Jui...
Journal of the Formosan Medical Association.  121 (2022)  12 - p. 2430-2437 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Real-World Effectiveness of Adjuvant Oxaliplatin Chemothera..:

Huang, Wen-Kuan ; Hsu, Hung-Chih ; Chang, Shu-Hao...
Frontiers in Pharmacology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
10

Preference criteria for regorafenib in treating refractory ..:

Hsu, Hung-Chih ; Huang, Kuo-Cheng ; Chen, Wei-Shone...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
11

Ramucirumab in patients with previously treated advanced he..:

Galle, Peter R. ; Kudo, Masatoshi ; Llovet, Josep M....
Liver International.  41 (2021)  11 - p. 2759-2767 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Assessment of pegylated arginine deiminase and modified FOL..:

Harding, James J. ; Yang, Tsai‐Sheng ; Chen, Yen‐Yang...
Cancer.  127 (2021)  24 - p. 4585-4593 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Real-world evidence of the safety and effectiveness of rego..:

Yeh, Kun-Huei ; Yang, Tsai-Sheng ; Hsu, Tzu-Chi...
Journal of the Formosan Medical Association.  120 (2021)  11 - p. 2023-2031 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Safety and Preliminary Efficacy of Ramucirumab in Combinati..:

Lin, Chia-Chi ; Yang, Tsai-Sheng ; Yen, Chia-Jui...
The Oncologist.  25 (2020)  12 - p. e1921-e1929 , 2020
Link: https://doi.org/10.1002/..
 
?
15

Postdiagnostic metformin use and survival of patients with ..:

Huang, Wen‐Kuan ; Chang, Shu‐Hao ; Hsu, Hung‐Chih...
International Journal of Cancer.  147 (2020)  7 - p. 1904-1916 , 2020
Link: https://doi.org/10.1002/..
 
1-15